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Accepted 10 March 2013AbstractObjective: We reanalyzed the data from a cluster-randomized controlled trial (C-RCT) of a quality improvement intervention for pre-
scribing antihypertensive medication. Our objective was to estimate the effectiveness of the intervention using both interrupted time-series
(ITS) and RCT methods, and to compare the findings.
Study Design and Setting: We first conducted an ITS analysis using data only from the intervention arm of the trial because our main
objective was to compare the findings from an ITS analysis with the findings from the C-RCT. We used segmented regression methods to
estimate changes in level or slope coincident with the intervention, controlling for baseline trend. We analyzed the C-RCT data using gen-
eralized estimating equations. Last, we estimated the intervention effect by including data from both study groups and by conducting a con-
trolled ITS analysis of the difference between the slope and level changes in the intervention and control groups.
Results: The estimates of absolute change resulting from the intervention were ITS analysis, 11.5% (95% confidence interval [CI]: 9.5,
13.5); C-RCT, 9.0% (95% CI: 4.9, 13.1); and the controlled ITS analysis, 14.0% (95% CI: 8.6, 19.4).
Conclusion: ITS analysis can provide an effect estimate that is concordant with the results of a cluster-randomized trial. A broader
range of comparisons from other RCTs would help to determine whether these are generalizable results.  2013 Elsevier Inc. All rights
reserved.
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Rigor and feasibility are often conflicting goals in the
choice of study designs for evaluating health system inter-
ventions [1]. Randomized trials may be difficult to conduct
for both practical and political reasons [2,3]. Simple but
weak evaluation designs, such as comparing outcomes be-
fore and after an intervention, are often feasible but may
yield misleading findings [4,5]. The high cost and slow
pace of randomized, controlled trials (RCTs) can also im-
pede their use in health systems research [6], although they
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http://dx.doi.org/10.1016/j.jclinepi.2013.03.016observational studies [7]. Unfortunately, little is known
about the relative validity of different approaches to evalu-
ating the effectiveness of health system interventions, be-
yond theoretical arguments. The need for more empirical
evidence on the validity of findings from randomized and
nonrandomized study designs was recently emphasized by
the Methodology Committee of the Patient-Centered Out-
comes Research Institute [8].
In one such design, interrupted time-series (ITS) analy-
sis, data collected at multiple time points before and after
an intervention are evaluated to determine whether the in-
tervention produced a discontinuity (change in level or
slope) in comparison with the underlying secular trend
[9]. This method is promoted as ‘‘a particularly strong
quasi-experimental alternative to randomized designs when
the latter are not feasible’’ [10, p. 172]. Frequently, the data
used in ITS analyses of health system interventions are
collected routinely as part of the delivery of care or the re-
imbursement process. Thus, this approach may be an attrac-
tive option that is both feasible and rigorous. However, to
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 An interrupted time-series analysis yielded an ef-
fect estimate that is concordant with a conventional
cluster, randomized, controlled trial analysis.
 This finding provides empirical support for the hy-
pothesis that interrupted time-series analyses can
provide reliable estimates of the effects of health
system interventions.
 A broader range of comparisons would help to de-
termine whether the findings from this study are
generalizable.our knowledge, no empirical studies have explored whether
effect estimates from an RCT would be replicated by ITS
analyses of the same data.
Between April 2002 and December 2003, we (A.F. and
A.O.) conducted a cluster-randomized, controlled trial
(C-RCT) with primary care physicians in Norway:ethe
Rational Prescribing in Primary Care (RaPP)dtrial [11].
The trial was financed by the Norwegian Ministry of
Health, motivated by the increased use of newer, expensive
drugs for cardiovascular risk reduction, such as calcium
channel blockers and angiotensin receptor blockers that
are generally no more effective than older, less expensive
medications.
We developed a multifaceted intervention, including
educational outreach visits and computerized reminders,
to encourage increased use of recommended antihyperten-
sive medication (low-dose diuretics) [11]. A total of 146
primary care practices from two areas of Norway were
recruited (participation rate, 38%), half of which were
randomized to receive the intervention. We block random-
ized within two geographical areas to ensure balance in
the number of practices in the intervention and control
groups. The size of the blocks varied randomly between
two, four, and six. The allocation list was generated by
a colleague not directly involved in the research project
with software from http://www.randomization.com. We
gave our colleague identification numbers that represented
each recruited practice, and she informed us whether the
practice was allocated to the intervention or control group
[11].
Practices in the intervention group were visited by
a trained pharmacist who presented the physicians with
recently published clinical guidelines that included a recom-
mendation to use low-dose diuretics as first-line antihyper-
tensive medication. We installed a software package during
the visit that enabled extraction of data from the electronic
medical record system and immediate feedback to the
physicians regarding their current prescribing practices.
The software also provided on-screen reminders aboutrecommended first-line medication, which were triggered
when patients returned after any recording of high blood
pressure. Outcome data were collected from electronic
medical records. The flow of participating practices is
shown in Fig. 1.
The intervention proved successful. The trial showed
that prescribing the recommended antihypertensive drugs
doubled in the intervention group compared with the con-
trol practices [11]. The analysis followed the conventional
approach of comparing outcomes in the two groups aggre-
gated over the intervention period, while adjusting for dif-
ferences between the groups during the preintervention
period.
After the trial was completed, we questioned whether
the results would have been similar if we had used ITS
analysis instead of conducting an RCT. The prescription
data we collected for this trial were dated, providing an op-
portunity to investigate this question by analyzing the data
with both methods. The objective of study was to compare
the effect estimates of these two approaches.2. Methods
We reanalyzed the primary outcome from the trial with
data most suitable for ITS analysis: prescribing low-dose
diuretics. The data from the trial included all prescriptions
for patients initiated on antihypertensive medication during
the year before and the year after the launch of the interven-
tion. To accommodate the ITS analysis, we decided to ex-
clude a small number of prescriptions (n 5 178) from more
than 12 months before or more than 12 months after the in-
tervention, which had been included in the original trial
analysis. We did this before running the analyses.
The C-RCT effect estimate was recalculated by compar-
ing the postintervention proportions of recommended pre-
scribing in the intervention and control groups, using
baseline prescribing levels for each practice as covariates
(analysis of covariance) in a generalized estimating equa-
tion model incorporating all observations (prescriptions)
while controlling for clustering effectsda recommended
approach to analysis of cluster trials [12]. The reanalysis
of the C-RCT was done to ensure that the same data were
used for the C-RCT and the ITS analysis, and that the same
metric was used for effect estimates (absolute risk
differences).
Initially, we conducted the ITS analysis using data only
from the intervention arm of the trial, because our main ob-
jective was to compare the findings from a single-group ITS
analysis with the findings from the C-RCT. This addressed
our original research question directly: What would the
findings have been had we conducted a simple, uncon-
trolled ITS analysis rather than a C-RCT? All prescriptions
were organized according to the number of days before or
after the intervention took place, from which we con-
structed a time series of monthly rates of prescribing of
Fig. 2. Prescribing of low-dose diuretics during the pre- and post-
intervention periods.
Fig. 1. Flow of practices in the RaPP-trial [11].
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tal of 24 data points). The number of prescriptions per
month was more than 100, which is recommended as a
minimum number of observations per time point for ITS
analysis [13].
We used segmented regression methods to estimate
changes in level or slope coincident with the intervention,
controlling for baseline trend (during 12 preintervention
months) [13]. The intervention effect was assumed to occur
immediately after implementation, so we decided not to in-
clude a transition period in the ITS analysis. To combine
both the immediate impact (level change) and the impact
on trend (slope change) in one effect metric, we modeled
the ITS effect estimate halfway through the postinterven-
tion period. The difference between the level of the prein-
tervention regression line projected halfway through the
postperiod, and the level of the postintervention line at
the same time point was used as the ITS effect estimate.
This would be comparable with the average effect for the
full 12-month period computed in the RCT. We used auto-
regressive integrated moving average modeling with back-
ward elimination (threshold for retaining coefficients,
P ! 0.2), and took autocorrelation into account by means
of an AR1 (autoregressive first order) model.
Last, we also decided to estimate the intervention effect
by including data from both study groups and conducting
a controlled ITS analysis of the difference between the in-
tervention and control groups in the C-RCT. A monthly
time series was constructed for the control group using
the same approach as that of the initial ITS analysis of
the intervention group only. Subtraction of control group
data points from intervention data points, for each month,
yielded a time series of data points representing the differ-
ence between the two groups. The calculations were done
in Stata 12.0 (Stata Corp, College Station, TX) using the
arima and xtgee commands.
We assessed the concordance (i.e., consistency) of the
estimates qualitatively, taking into consideration the magni-
tude of the differences in the point estimates and the extent
to which the confidence intervals overlapped.3. Results
Our C-RCT analyses included 139 practices (9,133 pre-
scriptions). The estimated outcome measures in the exper-
imental and control groups for the pre- and postintervention
periods are shown graphically in Fig. 2. The estimated in-
tervention effect was an increase of 9.0% (range, 4.9%
e13.1%) in the prescribing of recommended antihyperten-
sive medications.
The 70 practices (4,874 prescriptions) in the intervention
group were included in the first ITS analysis. The aggre-
gated monthly data points for the intervention group are
shown in Fig. 3. The graph supports our assumption that
the intervention would have an immediate effect. The
change in prescribing during the preintervention period
(0.1%/mo; 95% CI: e0.5, 0.3) and the change in trend
from the pre- to the postintervention period (0.3%/mo;
95% CI: e0.3, 0.9) were nonsignificant and therefore not
included in the model. Consequently, both the pre- and
the postintervention regression lines are flat (Fig. 3). The
autocorrelation term was nonsignificant and excluded from
the final model. The estimated intervention effect from the
ITS analysis was an increase of 11.5% (95% CI: 9.5, 13.5)
in the prescribing of recommended antihypertensive
medications.
The controlled ITS analysis of the differences between
the interventions and control groups is shown graphically
in Fig. 4. Again we found an immediate and sustained level
change and no change in trend from before to after the in-
tervention. The estimated intervention effect from the con-
trolled ITS analysis was an increase of 14.0% (range, 8.6%
e19.4%) in the rate of recommended prescribing.
We also conducted the ITS analyses with and without
control group data using generalized estimating equation
modeling that included patient-level data and controlled
for cluster effects. The results were similar to the findings
from the aggregated ITS analyses: 11.9% (95% CI: 8.7,
15.0) for the single-group ITS and 16.1% (95% CI, 9.2,
23.1) for the controlled ITS analysis.
Fig. 3. Monthly prescribing rates of low-dose diuretics with fitted seg-
mented linear regression lines.
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In the case of the Norwegian RaPP trial, a single-group
ITS analysis yielded a higher point estimate than the
C-RCT analysis (12 percentage points vs. 9 percentage
points), but a lower point estimate than the controlled ITS
analysis (12 vs. 14). However, the single-group ITS analy-
sis estimate was within the 95% confidence limits of both
the other estimates. Thus, in this case, we conclude that
the single-group ITS analysis yielded a reliable effect
estimate.
This finding is consistent with those of Schneeweiss
et al. [7], who found concordant results between a parallel
C-RCT and ITS analysis of the effects of a reimbursement
restriction of nebulised respiratory therapy in adults. A
strength of our comparison is that we reanalyzed before
and after data from the same practices in both the C-RCT
and the ITS analyses. ITS analyses are widely considered
the method of choice for rigorous evaluation of the effects
of interventions when RCTs are not feasible [9,10], and our
findings are compatible with that view. The feasibility ofFig. 4. Difference between the monthly prescribing rates of low-dose
diuretics in control and intervention groups, with fitted segmented lin-
ear regression lines.ITS analysis depends on the availability of routine data of
acceptable qualitydfor example, case records from health
care institutions or health insurance claims. An increasing
number of routine databases are available that contain clin-
ical and administrative data that could be used for evalua-
tion purposes.
The main weakness of our study is that it is based on
a single case. Our findings will require replication in future
comparative studies. In some situations, such as the exam-
ple in the current study, both the RCT and the single-group
ITS approach can be used. The main argument favoring an
RCT is that the risk of bias is lower because both known
and unknown confounders are controlled for through ran-
domization. However, this requires a sufficient sample size,
which is difficult to achieve when there are a limited num-
ber of clusters that can be randomized. C-RCTs with a small
number of clusters may, in fact, have a high risk of bias be-
cause of potential confounders. The baseline difference be-
tween the groups in the current study (Figs. 2 and 4),
resulting from ‘‘bad luck randomization,’’ give reason to
question the comparability of the two groups. The single-
group ITS likely yields a better estimate if the control
group does not serve as a valid comparator. If we do elect
to include the control group in the analysis, the question is
whether to take into account the difference in trend during
the baseline period (Fig. 4), which is the main difference
between the C-RCT and controlled ITS analyses. When an-
alyzed separately, neither the control nor the intervention
group display a statistically significant trend during the
baseline period. However, when the difference between
the two groups is used as the dependent variable, the coef-
ficient for trend qualifies for inclusion in the model
(P ! 0.2). The difference between the C-RCT and con-
trolled ITS estimates (9% vs. 14%) is explained by the fact
that we took change over time into account in the con-
trolled ITS analysis, but not in the C-RCT analysis. There
are no compelling theoretical or practical guidelines to de-
termine which of the three effect estimates is the most
valid.
The main risk of bias in ITS analyses is that observed
changes may be the result of factors other than the interven-
tion under evaluation. Potential advantages with ITS analy-
ses can be lower costs and greater speed, although this is
not always the case [7]. In the case of the RaPP trial, using
a single-group ITS analysis would probably have shortened
the project period by around 6 months, because half as
many practices would have been needed for the study (only
intervention practices) compared with a trial that also in-
cluded control practices.5. Conclusion
In this study, a single-group ITS analysis yielded an ef-
fect estimate similar to a conventional C-RCT analysis or
a controlled ITS analysis. A broader range of comparisons
887A. Fretheim et al. / Journal of Clinical Epidemiology 66 (2013) 883e887from other RCTs would help to determine whether these
are generalizable results.Acknowledgments
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